ATN-224

· Attenuon

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ATN-224, covering 2007-12-06 to 2013-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer [Phase 2]

See pricing